IL294571A - rspo1 proteins and their uses - Google Patents

rspo1 proteins and their uses

Info

Publication number
IL294571A
IL294571A IL294571A IL29457122A IL294571A IL 294571 A IL294571 A IL 294571A IL 294571 A IL294571 A IL 294571A IL 29457122 A IL29457122 A IL 29457122A IL 294571 A IL294571 A IL 294571A
Authority
IL
Israel
Prior art keywords
protein
rspo1
seq
spondin
functional
Prior art date
Application number
IL294571A
Other languages
English (en)
Hebrew (he)
Inventor
COLLOMBAT Patrick
SILVANO Serena
Original Assignee
Inst Nat Sante Rech Med
Centre Nat Rech Scient
Univ Cote D'azur
COLLOMBAT Patrick
SILVANO Serena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Centre Nat Rech Scient, Univ Cote D'azur, COLLOMBAT Patrick, SILVANO Serena filed Critical Inst Nat Sante Rech Med
Publication of IL294571A publication Critical patent/IL294571A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL294571A 2020-01-10 2021-01-08 rspo1 proteins and their uses IL294571A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20305016 2020-01-10
PCT/EP2021/050289 WO2021140209A1 (en) 2020-01-10 2021-01-08 Rspo1 proteins and their use

Publications (1)

Publication Number Publication Date
IL294571A true IL294571A (en) 2022-09-01

Family

ID=69185555

Family Applications (1)

Application Number Title Priority Date Filing Date
IL294571A IL294571A (en) 2020-01-10 2021-01-08 rspo1 proteins and their uses

Country Status (10)

Country Link
US (1) US20230241161A1 (cg-RX-API-DMAC10.html)
EP (1) EP4087863A1 (cg-RX-API-DMAC10.html)
JP (2) JP7767289B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220152202A (cg-RX-API-DMAC10.html)
CN (1) CN114929731A (cg-RX-API-DMAC10.html)
AU (1) AU2021205639A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022013468A2 (cg-RX-API-DMAC10.html)
CA (1) CA3163861A1 (cg-RX-API-DMAC10.html)
IL (1) IL294571A (cg-RX-API-DMAC10.html)
WO (1) WO2021140209A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024210262A1 (en) * 2023-01-19 2025-07-10 Centre National De La Recherche Scientifique Recombinant variants of r-spondin proteins and their use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US5179017A (en) 1980-02-25 1993-01-12 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4634665A (en) 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
GB8725529D0 (en) 1987-10-30 1987-12-02 Delta Biotechnology Ltd Polypeptides
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
HUE027179T2 (en) 2006-10-20 2016-10-28 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Angiogenesis and vasculogenesis modulator for Rspond
WO2008088524A2 (en) * 2006-12-28 2008-07-24 Nuvelo, Inc. Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor
ES2769786T3 (es) * 2011-10-14 2020-06-29 Recordati Ag Anticuerpos y métodos para enfermedades relacionadas con la vía Wnt
WO2014059068A1 (en) * 2012-10-11 2014-04-17 The Trustees Of The University Of Pennsylvania Methods for the treatment and prevention of osteoporosis and bone-related disorders
WO2016193497A1 (en) * 2015-06-04 2016-12-08 Ospedale San Raffaele Srl Inhibitor of igfbp3/tmem219 axis and diabetes
JP2021020900A (ja) 2019-07-29 2021-02-18 国立大学法人北海道大学 糖代謝異常改善剤
IL310154A (en) * 2021-07-15 2024-03-01 Diogenx Recombinant variants of r-spondin proteins and their use

Also Published As

Publication number Publication date
AU2021205639A1 (en) 2022-07-14
KR20220152202A (ko) 2022-11-15
BR112022013468A2 (pt) 2022-09-13
CN114929731A (zh) 2022-08-19
JP2023509189A (ja) 2023-03-07
JP7767289B2 (ja) 2025-11-11
EP4087863A1 (en) 2022-11-16
US20230241161A1 (en) 2023-08-03
WO2021140209A1 (en) 2021-07-15
CA3163861A1 (en) 2021-07-15
JP2026021430A (ja) 2026-02-10

Similar Documents

Publication Publication Date Title
JP6250714B2 (ja) Fgf21突然変異体及びその使用
JP5823954B2 (ja) Fgf21変異体及びその使用
US20230031280A1 (en) Glp-2 fusion polypeptides and uses for treating and preventing gastrointestinal conditions
US20180280474A1 (en) Treatment of bile acid disorders
JP2026021430A (ja) Rspo1タンパク質およびその使用
US20230340044A1 (en) Recombinant variants of r-spondin proteins and their use
TW202430543A (zh) R-spondin蛋白的重組變體及其用途
CN117980323A (zh) R-spondin蛋白的重组变体及其用途